Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: Rationale and design of the DECREASE-IV study

Olaf Schouten, Don Poldermans, Loes Visser, Miklos D. Kertai, Jan Klein, Hero Van Urk, Maarten L. Simoons, Louis L. Van De Ven, Maarten Vermeulen, Jeroen J. Bax, Thomas W. Lameris, Eric Boersma

Research output: Contribution to journalArticle

71 Citations (Scopus)
Original languageEnglish
Pages (from-to)1047-1052
Number of pages6
JournalAmerican Heart Journal
Volume148
Issue number6
DOIs
Publication statusPublished - Dec 1 2004

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Schouten, O., Poldermans, D., Visser, L., Kertai, M. D., Klein, J., Van Urk, H., Simoons, M. L., Van De Ven, L. L., Vermeulen, M., Bax, J. J., Lameris, T. W., & Boersma, E. (2004). Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery: Rationale and design of the DECREASE-IV study. American Heart Journal, 148(6), 1047-1052. https://doi.org/10.1016/j.ahj.2004.05.046